Stereotaxis to be featured prominently in 31st HRS

Stereotaxis' (Nasdaq: STXS) safety and efficacy in the treatment of patients with complex arrhythmias such as atrial fibrillation, ventricular tachycardia, and congenital heart defects will be featured prominently in the scientific program of the 31st Annual Heart Rhythm Scientific Sessions in Denver, Colorado.  Eight podium presentations and eight posters will underscore the broad clinical leadership that Stereotaxis has achieved in the treatment of patients with complex cardiac arrhythmias. Stereotaxis will display its advanced tools for the electrophysiology lab in booth # 1103.

In addition, Dr. J. Peter Weiss and his colleagues from Intermountain Medical Center in Salt Lake City, Utah will present a live case using a non-localized magnetic catheter in a patient with left-sided atrial flutter remotely from the control room of their fully integrated Odyssey lab in Salt Lake City.  The case will be presented on Thursday, May 13th at 10:30 am in the Four Seasons Ballroom 3-4.


Catheter ablation for atrial fibrillation is in high demand, with some studies indicating that the procedure is significantly growing each year.  Dr. Arash Arya and colleagues from the Heart Center, University of Leipzig in Leipzig, Germany, will present the poster, "Catheter Ablation of Atrial Fibrillation Using Remote Magnetic Catheter Navigation: A Case-Control Study" during Poster Session 6 on Saturday, May 15th at 9 a.m. in the main exhibit hall.

Additional data will be presented by Dr. David Burkhardt and colleagues at St. David's Medical Center in Austin, Texas during Poster Session 4 on Friday, May 14th at 9 a.m. and by Dr. Shinsuke Miyazaki and physicians from Hopital Cardiologique du Haut-Leveque in Bordeaux, France during Poster Session 5 on Friday, May 14th at 2:00 p.m., both in the main exhibit hall.


The congenital heart defect patient group is one of the most challenging populations facing the electrophysiologist and particularly attractive for treatment with the advanced tools offered by Stereotaxis.  Dr. Thomas Baurnfeind from the Thoraxcenter at Erasmus Medical Center in Rotterdam, The Netherlands will present the paper, "The Usefulness of Ablation Guided by Remote Navigation in Patients with Complex Congenital Heart Disease." This paper will be presented on Thursday, 5/13 at 2:15 pm in Room 102.


Due to complex anatomy, the sensitive nature of ventricular tissue, and potentially lethal outcomes, treating ventricular tachycardia is a major challenge for electrophysiologists, and requires the delivery of robust lesions for clinical success.

As previously announced, Hiroshi Nakagawa, MD, PhD, Co-Director of the Heart Rhythm Institute at the University of Oklahoma Health Sciences Center will deliver a podium presentation titled "Substrate Ablation of Scar Ventricular Tachycardia Using Magnetic Catheter Maneuvering System," on Friday, May 14, at 2:45 pm, Korbel Ballroom 4F.  Additionally, Petr Neuzil, MD, PhD, from Na Holmoce Hospital in Prague, will present a poster with early results from the "Stereotaxis Study to Obliterate Persistent Ventricular Tachycardia" or "STOP-VT" study during Poster Session 2 on Thursday, May 13th at 9:00 a.m. in the main exhibit hall.  

"We are very excited to see the results from two important VT studies," said Michael P. Kaminski, President and CEO of Stereotaxis. "VT is among the most challenging arrhythmias to treat.  There are a growing number of patients with VT and a limited number of clinicians who perform the complex procedure, creating few options for patients.  Based on what we're seeing at several centers performing VT ablations routinely, we believe that catheter ablation with magnetic navigation can effectively terminate a high majority of documented ventricular tachycardias, particularly among patients who had previously suffered a heart attack."


An innovative Odyssey Network will be featured throughout the HRS exhibit floor including demonstrations in the Siemens Medical Solutions, Philips Medical Systems, and Biosense Webster booths.  Odyssey will also support a live interactive demonstration of the Stereotaxis magnetic navigation system through a remote VPN connection between Denver and St. Louis.  Customers will have an opportunity to receive a hands-on demonstration of the comprehensive Odyssey Enterprise Solution with its fully integrated, real-time information management platform to integrate, record, and network interventional lab data throughout hospitals and around the world.

"The broad showcase of Odyssey at this year's HRS validates the level of interest building among customers and partners," said Michael P. Kaminski.  "We believe that the combination of our partner solutions coupled with the unique benefits of Odyssey provides customers with an innovative platform that addresses unmet customer needs from advanced treatment to referral outreach."


Stereotaxis, Inc.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Nitric oxide use in cardiopulmonary bypass surgery does not improve the recovery of children